Pramosone HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE SEBELA PHARMACEUTICALS INC. FDA Approved Pramosone ® Ointment is a topical preparation containing hydrocortisone acetate 1% w/w or 2.5% w/w and pramoxine hydrochloride 1% w/w in an emollient ointment base containing sorbitan sesquioleate, purified water, Aquaphor ® , and white petrolatum. Topical corticosteroids are anti-inflammatory and anti-pruritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below. hydrocortisone acetate Pregn-4-ene-3, 20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11-beta)- C 23 H 32 O 6 ; mol. wt: 404.50 pramoxine hydrochloride 4-(3-(p-butoxyphenoxy)propyl)morpholine hydrochloride C 17 H 27 NO 3 ,HCl: mol. wt: 329.87 hydrocortisoneacetate pramoxinehcl
FunFoxMeds box
Route
TOPICAL
Package NDC

Drug Facts

Composition & Profile

Strengths
1 % 2.5 %
Treats Conditions
Indications And Usage Topical Corticosteroids Are Indicated For The Relief Of The Inflammatory And Pruritic Manifestations Of Corticosteroid Responsive Dermatoses

Identifiers & Packaging

Container Type UNKNOWN
All Product Codes
UPC
0354766777042
UNII
3X7931PO74 88AYB867L5
Packaging

HOW SUPPLIED: Pramosone® Ointment 1% 1 oz tube (NDC 54766-763-04) Pramosone® Ointment 2.5% 1 oz tube (NDC 54766-777-04) Storage Conditions: Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Rx Only. Manufactured for Sebela Ireland Ltd. By Ferndale Laboratories, Inc. Ferndale, MI 48220 U.S.A. Distributed By Sebela Pharmaceuticals Inc. 645 Hembree Parkway, Suite I Roswell, Georgia 30076 www.sebelapharma.com Toll free 1-844-732-3521 PI777040215 Rev. Feb. 2015 Aquaphor® is a registered trademark of Beiersdorf AG. Pramosone® is a registered trademark of Sebela International Ltd. #6989I ©2015 Reproduction prohibited; Principal Display Panel - NDC 54766-777-04 – 1oz Ointment PramOintment2.5Rev1212

Package Descriptions
  • HOW SUPPLIED: Pramosone® Ointment 1% 1 oz tube (NDC 54766-763-04) Pramosone® Ointment 2.5% 1 oz tube (NDC 54766-777-04) Storage Conditions: Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Rx Only. Manufactured for Sebela Ireland Ltd. By Ferndale Laboratories, Inc. Ferndale, MI 48220 U.S.A. Distributed By Sebela Pharmaceuticals Inc. 645 Hembree Parkway, Suite I Roswell, Georgia 30076 www.sebelapharma.com Toll free 1-844-732-3521 PI777040215 Rev. Feb. 2015 Aquaphor® is a registered trademark of Beiersdorf AG. Pramosone® is a registered trademark of Sebela International Ltd. #6989I ©2015 Reproduction prohibited
  • Principal Display Panel - NDC 54766-777-04 – 1oz Ointment PramOintment2.5Rev1212

Overview

Pramosone ® Ointment is a topical preparation containing hydrocortisone acetate 1% w/w or 2.5% w/w and pramoxine hydrochloride 1% w/w in an emollient ointment base containing sorbitan sesquioleate, purified water, Aquaphor ® , and white petrolatum. Topical corticosteroids are anti-inflammatory and anti-pruritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below. hydrocortisone acetate Pregn-4-ene-3, 20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11-beta)- C 23 H 32 O 6 ; mol. wt: 404.50 pramoxine hydrochloride 4-(3-(p-butoxyphenoxy)propyl)morpholine hydrochloride C 17 H 27 NO 3 ,HCl: mol. wt: 329.87 hydrocortisoneacetate pramoxinehcl

Indications & Usage

: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage & Administration

: Topical corticosteroids are generally applied to the affected area as a thin film three to four times daily depending on the severity of the condition. Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressing should be discontinued and appropriate antimicrobial therapy instituted.

Warnings & Precautions
No warnings available yet.
Contraindications

: Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Foliculitis Hypertrichosis Acneiform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis Maceration of the skin Secondary infection Skin atrophy Striae Miliaria

Storage & Handling

Storage Conditions: Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Rx Only. Manufactured for Sebela Ireland Ltd. By Ferndale Laboratories, Inc. Ferndale, MI 48220 U.S.A. Distributed By Sebela Pharmaceuticals Inc. 645 Hembree Parkway, Suite I Roswell, Georgia 30076 www.sebelapharma.com Toll free 1-844-732-3521 PI777040215 Rev. Feb. 2015 Aquaphor® is a registered trademark of Beiersdorf AG. Pramosone® is a registered trademark of Sebela International Ltd. #6989I ©2015 Reproduction prohibited


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →